Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552355 · ClinicalTrials.gov registry record · Phase 2
Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin
A Phase 2 study, sponsored by Colorado State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT02552355 is a Phase 2 study that has completed, run by Colorado State University. The registered enrollment target is 56 participants.
The verdict
NCT02552355, a Phase 2 study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
The investigators propose that post-exercise milk protein feeding will enhance the mitochondrial protein synthesis (biogenesis) response to an exercise-training program. In addition, the investigators propose that this stimulatory effect of protein feeding will overcome the potential blunting effect of metformin on exercise responses. The investigators will investigate these outcomes over a 12-week exercise-training program in older adults with pre-diabetes with or without metformin treatment.
Interventions
- DRUG Placebo
- DRUG Metformin
- DIETARY_SUPPLEMENT Carbohydrate Beverage
- DIETARY_SUPPLEMENT Protein Beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02552355
The ClinicalTrials.gov registry entry for NCT02552355 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02552355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02552355 about?
NCT02552355 is a clinical study titled "Milk Protein Feeding After Aerobic Exercise in Older Adults With Pre-diabetes Taking the Biguanide Metformin". The investigators propose that post-exercise milk protein feeding will enhance the mitochondrial protein synthesis (biogenesis) response to an exercise-training program. In addition, the investigators propose that this stimulatory effect of protein feeding will overcome the potential blunting effect...
What is the current status of trial NCT02552355?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2015-08. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02552355?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), Carbohydrate Beverage (DIETARY_SUPPLEMENT), Protein Beverage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02552355?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.